Results 181 to 190 of about 4,730,461 (228)

Study on the relationship between disease progression and changes in Th17/Treg levels in patients with relapsing-remitting multiple sclerosis. [PDF]

Front Neurol
Yang J, Xue Q, Wang X, Song A.
europepmc   +1 more source

A Stage-Dependent Translational Signature in Peripheral Blood Mononuclear Cells from Clinically Isolated Syndrome to Relapsing-Remitting Multiple Sclerosis: An Exploratory Cross-Sectional Study. [PDF]

Int J Mol Sci
D'Angiolini S, Minuti A.
europepmc   +1 more source

Abstracts of 14th International Symposium on Hodgkin Lymphoma

HemaSphere, Volume 10, Issue S2, October 2026.
wiley   +1 more source

Prevalence of Slowly Expanding Lesions in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis. [PDF]

Neurology
Liampas A, Artemiadis A, Tseriotis VS, Prados F, Preziosa P, Calvi A, Hadjigeorgiou G, Rocca MA, Filippi M, Ciccarelli O.   +9 more
europepmc   +1 more source

Ocrelizumab in early relapsing-remitting multiple sclerosis: first interim analysis of the MUSPO Italian prospective cohort. [PDF]

J Neurol
Filippi M, D'Amico E, Brescia Morra V, Zanetta C, Zanghì A, Di Filippo PS, Longobardi E, Colombo E, Mirabella M, Conte A, Tomassini V, Masini C, Perosino V, Tortorella P, Rocca MA, MUPSO Study Group.   +15 more
europepmc   +1 more source

Cardiovascular-Cognitive Associations During Physiological Challenges in Relapsing-Remitting Multiple Sclerosis. [PDF]

Diseases
Racosta JM, Arocha-Perez J, Seo DH, Ayromlou S, Riccio PM.   +4 more
europepmc   +1 more source

Pharmacokinetic-Pharmacodynamic Modelling of Repeated Ocrelizumab Dosing in Relapsing-Remitting Multiple Sclerosis. [PDF]

Clin Pharmacokinet
Serkland TT, Oma AF, Hallin EI, Øverås MH, Nygaard GO, Myhr KM, Torkildsen Ø, Röblitz S, Skrede S.   +8 more
europepmc   +1 more source